Cold environment exacerbates brain pathology and oxidative stress following traumatic brain injuries: Potential therapeutic effects of nanowired antioxidant compound H-290/51
dc.creator | Sharma A. | |
dc.creator | Muresanu D.F. | |
dc.creator | Lafuente J.V. | |
dc.creator | Sjöquist P.-O. | |
dc.creator | Patnaik R. | |
dc.creator | Tian Z.R. | |
dc.creator | Ozkizilcik A. | |
dc.creator | Sharma H.S. | |
dc.date.accessioned | 2020-09-02T22:28:13Z | |
dc.date.accessioned | 2022-11-08T20:26:30Z | |
dc.date.available | 2020-09-02T22:28:13Z | |
dc.date.available | 2022-11-08T20:26:30Z | |
dc.date.created | 2020-09-02T22:28:13Z | |
dc.date.issued | 2018 | |
dc.identifier | 55, 1, 276-285 | |
dc.identifier | 08937648 | |
dc.identifier | https://hdl.handle.net/20.500.12728/6244 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5146083 | |
dc.language | en | |
dc.publisher | Humana Press Inc. | |
dc.subject | Blood-brain barrier | |
dc.subject | Brain edema | |
dc.subject | Cold environment | |
dc.subject | Glutathione | |
dc.subject | H-290/51 | |
dc.subject | Lucigenin | |
dc.subject | Luminol | |
dc.subject | Malondialdehyde | |
dc.subject | Nanodelivery | |
dc.subject | Neuronal damage | |
dc.subject | Oxidative stress | |
dc.subject | Traumatic brain injury (TBI) | |
dc.subject | antioxidant | |
dc.subject | glutathione | |
dc.subject | H 290 51 | |
dc.subject | h 290 51 | |
dc.subject | lucigenin | |
dc.subject | luminol | |
dc.subject | malonaldehyde | |
dc.subject | nanowire | |
dc.subject | titanium dioxide | |
dc.subject | unclassified drug | |
dc.subject | antioxidant | |
dc.subject | H290-51 | |
dc.subject | indole derivative | |
dc.subject | nanowire | |
dc.subject | neuroprotective agent | |
dc.subject | animal experiment | |
dc.subject | animal model | |
dc.subject | animal tissue | |
dc.subject | Article | |
dc.subject | blood brain barrier | |
dc.subject | brain region | |
dc.subject | cold acclimatization | |
dc.subject | controlled study | |
dc.subject | disease exacerbation | |
dc.subject | dose response | |
dc.subject | drug delivery system | |
dc.subject | drug effect | |
dc.subject | edema | |
dc.subject | enzyme activity | |
dc.subject | enzyme blood level | |
dc.subject | male | |
dc.subject | neuropathology | |
dc.subject | neuroprotection | |
dc.subject | nonhuman | |
dc.subject | oxidative stress | |
dc.subject | parietal lobe | |
dc.subject | pathophysiology | |
dc.subject | rat | |
dc.subject | room temperature | |
dc.subject | traumatic brain injury | |
dc.subject | animal | |
dc.subject | brain | |
dc.subject | cold | |
dc.subject | metabolism | |
dc.subject | oxidative stress | |
dc.subject | pathology | |
dc.subject | physiology | |
dc.subject | Sprague Dawley rat | |
dc.subject | traumatic brain injury | |
dc.subject | treatment outcome | |
dc.subject | Animals | |
dc.subject | Antioxidants | |
dc.subject | Brain | |
dc.subject | Brain Injuries, Traumatic | |
dc.subject | Cold Temperature | |
dc.subject | Indoles | |
dc.subject | Male | |
dc.subject | Nanowires | |
dc.subject | Neuroprotective Agents | |
dc.subject | Oxidative Stress | |
dc.subject | Rats | |
dc.subject | Rats, Sprague-Dawley | |
dc.subject | Treatment Outcome | |
dc.title | Cold environment exacerbates brain pathology and oxidative stress following traumatic brain injuries: Potential therapeutic effects of nanowired antioxidant compound H-290/51 | |
dc.type | Article |